Cholestatic liver disease affects Alkaline Phosphatase (ALP) and bilirubin levels, indicating bile duct damage. GGT and 5'-Nucleotidase help differentiate hepatobiliary vs. bone origin of ALP elevation. ALP is produced by bile duct epithelium and can be normal in acute biliary obstruction. GGT and N

1 views • 33 slides

Steatotic liver disease, including metabolic dysfunction associated steatohepatitis (MASLD) and metabolic associated alcoholic liver disease (MALD), is a common cause of liver test abnormalities in the United States. Risk factors such as obesity and metabolic syndrome can lead to advanced fibrosis a

1 views • 44 slides

Liver is the largest gland in our body, and an important metabolic organ which carries out many essential biological functions. The liver is a wedge-shaped, reddish-brown in color with two lobes of different size and shape. The approximate weight of a human liver is 1.5 kilograms. It is in the upper

5 views • 2 slides

Liver complications in cystic fibrosis (CF) have gained importance due to CFTR modulators impacting liver health. This presentation by Dr. Zachary M. Sellers delves into new definitions for CF liver disease, CFF recommendations for screening, management, and treatment of hepatobiliary issues in CF.

0 views • 17 slides

Best Liver Transplant Hospitals in India\nThe liver is a vital organ that performs important functions in the human body, including detoxification, metabolism, and the production of essential proteins. However, certain conditions such as liver failure, cirrhosis, or liver cancer may necessitate a li

0 views • 2 slides

At Brain Injury Services, we are committed to making a positive difference in the lives of individuals affected by brain injury. Through our comprehensive support services, compassionate care, and commitment to empowerment, we empower survivors to overcome obstacles, reclaim their independence, and

6 views • 7 slides

In this informative content, the histological structures of the liver and spleen are explored in detail. Key components such as hepatocytes, sinusoids, bile canaliculi, and the spaces of Disse in the liver, and the white pulp and red pulp in the spleen are highlighted. The classic liver lobule, cent

1 views • 10 slides

Translational Liver Consortia (TLC) and the Translational Hepatocellular Carcinoma Consortium (THCCC) led by Dr. Hashem B. El-Serag are focused on advancing research for early detection of liver cancer. The main objectives include patient stratification for liver cancer risk, surveillance in cirrhos

0 views • 25 slides

Urea is synthesized in the liver through a series of enzymatic steps known as the urea cycle or Krebs-Henseleit cycle. This process involves converting toxic ammonia into urea, a less toxic and water-soluble compound that can be easily excreted in urine. The liver plays a crucial role in urea biosyn

1 views • 20 slides

The Annual Report on Liver Transplantation 2021/22 presents detailed statistics and clinical research findings from the NHS Blood and Transplant BLTG Transplant Meeting in September 2022. The report covers an overview, transplant list, donor and organ supply, transplant activity, and outcomes. It hi

0 views • 45 slides

These slides provide an in-depth overview of the EASL clinical practice guidelines on managing drug-induced liver injury. The guidelines cover epidemiology, key recommendations, future prospects, new biomarkers, unresolved issues, and unmet needs. Recommendations are based on evidence levels from th

0 views • 44 slides

The liver services at Imperial College Healthcare NHS Trust, led by Dr. Ameet Dhar, provide a comprehensive range of services for patients with liver conditions. With over 2000 new patients seen annually, services include inpatient care, specialist clinics, outreach programs, and referral pathways.

0 views • 14 slides

Abnormal liver function tests can be a perplexing issue with various underlying causes. Dr. Heather Lewis, a renowned Consultant Hepatologist at Imperial College Healthcare NHS Trust, sheds light on the significance of liver function tests, liver enzymes, and blood markers in diagnosing liver condit

0 views • 21 slides

These slides provide a comprehensive overview of the EASL clinical practice guidelines on nutrition in chronic liver disease. The guidelines were first presented at the International Liver Congress 2018 and will soon be published in the Journal of Hepatology. The content covers methods of grading ev

6 views • 37 slides

Understanding the natural history, evaluation, and management of benign liver lesions is crucial for diagnosing incidental liver findings. Common benign liver lesions include hepatic hemangioma, focal nodular hyperplasia, hepatic adenoma, and hepatic cyst. Differential diagnosis plays a key role in

0 views • 37 slides

Delve into a comprehensive overview of the liver's anatomy, including ligaments, blood supply, and structure in the hilum. Explore the vital functions performed by the liver, such as maintaining body temperature, synthesizing clotting factors, and drug metabolism. Discover liver function tests and t

3 views • 22 slides

Liver biopsy plays a crucial role in diagnosing, staging, and prognostic evaluation of liver diseases in children. Indications for liver biopsy include diagnostic, prognostic, and monitoring purposes. Specific scenarios like neonatal cholestasis and progressive familial intrahepatic cholestasis requ

2 views • 47 slides

The liver plays a crucial role in detoxification and maintaining harmony in the body according to Traditional Chinese Medicine (TCM). Issues like liver disharmony can lead to various symptoms and health conditions. TCM emphasizes the importance of supporting liver function for overall well-being by

0 views • 21 slides

A phase 2 study on NGM282 in NASH patients showed a significant decrease in liver fat content, meeting the primary endpoint. Exploratory findings also indicated potential improvements in liver histology. The treatment involved NGM282 at 3 mg QD, with additional rosuvastatin if needed. Promising resu

0 views • 11 slides

Cellular injury can occur due to various factors like physical trauma, chemicals, radiation, and biologic agents. This process can lead to reversible or irreversible damage in cells, affecting their normal functions and possibly leading to cell death. Manifestations of cellular injury include cellul

0 views • 9 slides

Comprehensive discussion on assessing patients with abnormal liver test results, focusing on distinguishing between acute and chronic liver conditions. Covers diagnostic workup, patient cases, and differential diagnosis, emphasizing the importance of patient history, physical examination, and key di

0 views • 16 slides

This comprehensive review discusses the pharmacotherapy options for Non-Alcoholic Fatty Liver Disease (NAFLD), covering topics such as sub-classification of NAFLD, proposed risk stratification, non-invasive measures for assessing liver fibrosis, and the NAFLD Activity Score (NAS). Anita Eftekharzade

0 views • 44 slides

The National Liver Review Board, led by Dr. Ryutaro Hirose at the University of California, San Francisco, aims to address inconsistencies in liver transplant applications and approvals across UNOS regions. The board focuses on eliminating disparities in acceptance rates, refining approval practices

0 views • 18 slides

CYNOBIL liver capsules offer comprehensive liver support with a natural blend of silymarin, artichoke extract, and NAC. Improve liver function, detox, and digestion with CYNOBIL by LYF Healthcare.\n

0 views • 3 slides

The World Drug Report 2020 highlights the strong correlation between socioeconomic factors and drug use disorders. Studies reveal that communities facing poverty, violence, and social inequality are at a higher risk of drug overdoses and addiction. Factors like income inequality, lack of social capi

0 views • 17 slides

Steatosis has emerged as a significant diagnosis with NAFLD becoming a common cause for hepatologic evaluation. Liver stiffness measurement (LSM) using transient elastography is vital for assessing fibrosis severity in NAFLD patients. However, the accuracy of LSM can be influenced by obesity and sev

0 views • 35 slides

Hepatobiliary and pancreatic disorders can lead to conditions like jaundice, caused by an accumulation of bilirubin. Jaundice can be classified as prehepatic, intrahepatic, or posthepatic depending on the underlying causes such as liver damage, hepatitis, cirrhosis, or bile duct obstructions. Liver

0 views • 26 slides

Targeted clinical investigation plays a crucial role in pharmacovigilance by further evaluating significant risks identified in pre-approval clinical trials. This involves conducting pharmacokinetic and pharmacodynamic studies, genetic testing, interaction studies, and large simplified trials to ass

0 views • 12 slides

This presentation discusses the principles, causes, presentations, management, and prognosis of acute liver disorders, with a focus on insult to the normal liver leading to liver injury, inflammation, and necrosis. It covers causes such as drugs, viruses, ischemia, autoimmune conditions, Budd-Chiari

0 views • 16 slides

Faraday's Law of Induction states that a changing magnetic field induces an electromotive force (emf) in a conductor, producing an induced current. Lenz's Law complements this by determining the direction of the induced current to oppose the change in magnetic field. This phenomenon is demonstrated

0 views • 23 slides

Acute liver disorders can have various causes such as drugs, viruses, ischemia, autoimmune conditions, and more. The presentations of acute liver disease can include abnormal liver tests, jaundice, liver impairment, and even liver failure. Management involves removing and treating the underlying cau

0 views • 16 slides

Drug-Induced Liver Injury (DILI) is a serious concern that can lead to fatal liver damage, affecting drug development and potentially causing market withdrawal. This article explores the importance of DILI awareness, the critical functions of the liver, common causes of liver failure, and the backgr

0 views • 24 slides

Guideline drafted by Dr. Sally Hull and Dr. Lucy Carter focuses on identifying patients at risk of chronic liver disease, increasing testing for treatable liver conditions, and auditing prevalence of major liver diseases. The importance of diagnosing Non-Alcoholic Fatty Liver Disease (NAFLD) and str

0 views • 23 slides

Update report on liver and intestinal organ transplantation committee activities, including developing materials to educate liver regional review board members, strategic planning, addressing operational guidelines affecting the review process, and implementing a National Liver Review Board followin

0 views • 11 slides

Dr. Somen Banerjee, Director of Public Health in London Borough Tower Hamlets, highlights the concerning liver disease mortality rates in the area, with high incidence of cirrhosis, cancer, and hepatitis B and C. The data reveals a significant burden of liver diseases such as Non-Alcoholic Fatty Liv

0 views • 18 slides

The liver carries out essential metabolic, excretory, protective, synthetic, and storage functions in the body. Liver function tests play a crucial role in screening for liver dysfunction, recognizing patterns of liver disease, assessing patient prognosis, monitoring disease progression, and evaluat

0 views • 48 slides

This presentation delves into the intricacies of acute kidney injury (AKI) and its occurrence in patients with liver disease in the intensive care unit (ICU). It covers the definitions, classifications, and causes of AKI, emphasizing the Hepatorenal Syndrome, a form of functional renal failure in en

0 views • 29 slides

Drug-induced liver injury (DILI) can present as cholestasis, hepatocyte necrosis, steatosis, vascular damage, and hepatic fibrosis. Various drugs like antibiotics, NSAIDs, recreational drugs, and herbal remedies can cause liver damage. Recognizing DILI is crucial in patients with liver dysfunction o

0 views • 9 slides

This guidance provides detailed information on COVID-19 and liver disease, covering topics such as COVID-19 overview, liver test abnormalities, co-morbidities, viral hepatitis B and C, metabolic dysfunction, autoimmune hepatitis, clinical care aspects, complications management, screening for HCC, an

0 views • 14 slides

The Drug-Free Workplace Act of 1988 mandates federal grant recipients to implement zero-tolerance drug policies to maintain a drug-free environment. Employers must establish clear policies, conduct awareness programs, offer counseling and rehabilitation services, and impose penalties for violations.

0 views • 19 slides